Changeflow GovPing Healthcare Cephea Valve Delivery System - Heart Valve Repl...
Routine Notice Added Final

Cephea Valve Delivery System - Heart Valve Replacement

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Prosthetics (A61F)
Published
Detected
Email

Summary

The European Patent Office published EP4138729A2 for Cephea Valve Technologies, Inc., covering a delivery system for heart valve replacement. The patent application was filed with claims related to A61F 2/24 (heart valve prostheses) and A61M 25/01 (catheter placement). The patent designates all EU member states plus Switzerland, Norway, and Turkey.

What changed

The EPO published a patent application (EP4138729A2) for Cephea Valve Technologies' heart valve delivery system, classified under A61F 2/24 and A61M 25/01. This A2 publication indicates the application passed written examination and is open for opposition.

Medical device manufacturers developing transcatheter heart valve delivery systems targeting the European market should assess this patent for potential infringement implications. Freedom-to-operate analyses for cardiac device products in designated states (DE, FR, IT, ES, GB, etc.) should account for this intellectual property grant.

What to do next

  1. Monitor for patent grant confirmation and validate freedom-to-operate in European markets

Archived snapshot

Apr 8, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

DELIVERY SYSTEM FOR HEART VALVE REPLACEMENT

Publication EP4138729A2 Kind: A2 Apr 01, 2026

Applicants

Cephea Valve Technologies, Inc.

Inventors

VON OEPEN, Randolf, COBAR, Hugo, A., VALENCIA, Francisco, SHELTON, Russell, Patrick, CHAN, Henry, Thek, HAYNES, Evelyn, N., HAYENGA, Kim, Lela, CATON, Curtis, James, HYDE, Gregory, Matthew, SHERMAN, Austin, Michael, MONTEON, Gabriel, H.

IPC Classifications

A61F 2/24 20060101AFI20221004BHEP A61M 25/01 20060101ALI20221004BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for ChangeBridge: EPO Bulletin - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
EPO
Published
April 1st, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4138729A2

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent publication Medical device IP Cardiac prostheses
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.